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1. Introduction 
Chromatographic differences between normal and 
leukemic lysozymes have been observed [ 1, 21. The 
peptide maps of the tryptic digests did not differ [2], 
however. The primary structures of lysozyme isolated 
from human milk [3] and from the urine of a patient 
with chronic monocytic leukemia [4] were found to 
be identical. 
In our laboratory amino acid analysis of a urinary 
lysozyme from a case of monocytic leukemia demon- 
strated the presence of 9 valine residues instead of 8 
as previously reported. No other discrepancies were 
found (table 1). 
2. Methods 
The lysozyme was isolated as described by Johans- 
son and Malmquist [6] . The lyophilized preparation 
contained no contaminating proteins detectable by 
agarose gel electrophoresis. Likewise, a rabbit anti- 
serum against the purified protein contained no detec- 
table antibodies against other proteins present in the 
urine sample used, or against serum proteins. 
Amino acid analysis was performed on a Beckman 
amino acid analyzer, Model 12OC. Hydrolysis was 
carried out according to Moore and Stein [7], Mat- 
subara and Sasaki [8], and Spencer and Wold [9], ex- 
cept that the air oxidation was omitted after the 
hydrolysis in the Moore and Stein procedure. The 
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hydrochloric acid used was prepared from analytical 
grade fuming hydrochloric acid (Merck, Darmstadt, 
W. Germany) and distilled and deionized water 1: 1 
(v/v). The hydrolyzates were evaporated to dryness as 
described by Brunfeldt and Thomsen [lo] . 
Automated Edman degradation [ 1 l] was carried 
out in a Beckman sequencer, Model 890B. The se- 
quence of the first 79 residues was established by re- 
peated degradations of the native lysozyme, the re- 
duced and carboxymethylated [ 121 lysozyme, and a 
fragment obtained after cyanogen bromide cleavage 
[13] of the RCM* lysozyme. So far, no deviation 
from the earlier reported sequence [3,4] was found. 
RCM human leukemia lysozyme (135 mg) in 0.2 M 
sodium hydroxide (25 ml) was reacted with 1,2-cyclo- 
hexanedione at a lo-fold molar excess over guanidino 
groups [ 141. The cyclohexanedione was vacuum sub- 
limated immediately before use [ 151. After 3 hr at 
room temp an equal volume of acetic acid was added 
and the modified lysozyme desalted on a column 
(2.5 X 75 cm) of Sephadex G-25 fine. Elution was 
performed with 50% acetic acid. The CHD-RCM lyso- 
zyme (135 mg) was digested at 37” with trypsin in 
0.2 M ammonium hydrogencarbonate, pH 7.8, (13 ml) 
1 X 10m3 M in calcium chloride. The digestion was 
initiated by the addition of 2.3 mg TPCK treated 
* Abbreviations: RCM = reduced and carboxymethylated. 
CHD = cyclohexanedione modified. TPCK = tosylamid@Z 
phenylethyl-chloromethyl ketone. 
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Table 1 
The amino acid composition of a human monocytic leukemia lysozyme. Residues per mole, calculated relative to aspartic acid, 
which is set to 18.0. 
Amino 
acid 
Native 
a) b) cl 
RCM 
ad) 
Per- 
formic 
acid 
oxid [5] 
al 
Nearest 
integer 
Human milk 
lysozyme [ 31 
and human 
leukemia 
lysozyme [4] 
TIP 
Lys 
His 
Arg 
CySO sH 
CMCys 
Asp 
Met@21 
Thr 
Ser 
Ghl 
pro 
C’Y 
Ala 
*cys 
Val 
Met 
Ile 
LeU 
‘b 
Phe 
Total 
1.4 
5.1 
1.1 
14.1 
18.0 18.0 18.0 
5.2 e) 
5.9e) 
9.leI 
4.2 f) 
11.0 
14.1 
3.8 
9.0 
2.0 
4.9 
8.0 
5.9 
2.1 
5.3 e) 4.3 5.2 e) 
5.6 el 3.2 6.3 e) 
9.4 e) 9.1 e) 9.le) 
6.10 2.1 2.1 
11.3 11.2 10.9 
14.3 13.9 13.9 
9.3 
2.0 
4.9 
8.1 
6.1 
2.2 
9.3 
1.0 
5.4 
7.9 
1.4 
4.9 e) 
5.1 
1.1 
14.4 
8.2 
5.0 
1.0 
14.0 
8.0 
18.0 
8.8 
1.8 
4.9 
8.0 
5.9 
2.1 
4.9 
1.0 
13.7 
6.9 
18.0 
2.0 
5.2e) 
6.le) 
9.0 e) 
1.3 
10.8 
13.8 
8.6 
4.8 
8.0 
5.6 
2.0 
5 5 
5 5 
1 1 
14 14 
18 18 
5 5 
6 6 
9 9 
2 2 
11 11 
14 14 
8g) 8 
9 8 
2 2 
5 5 
8 8 
6 6 
2 2 
130 129 
a) Hydrolyzed for 24 hr at 110” in 6 N HCl [ 71 air oxidation was omitted after the hydrolysis. 
b) Hydrolyzed for 24 hr at 110” in 6 N HCl containing 3% mercaptoacetic acid [ 81. 
c) Hydrolyzed for 24 hr at 110” in 6 N HCl containing 2% dimethylsulfoxide [ 91. 
d) Average of 3 determinations. 
e) Corrected according to experiments with hen egg-white lysozyme, Trp +17%, Thr +lO%, Ser +20%, Glu -4%. 
f) Proline + cysteine. 
g) Determined as cysteic acid or S-carboxymethylcysteine. 
bovine trypsin (Merck, Darmstadt, W. Germany) dis- 
solved in 100 ~1 buffer. The same amount was added 
after 2 and 4 hr. The final enzyme-substrate ratio 
was approx. 1:20 (w/w). The mixture was lyophilized 
after 6 hr of digestion. 
The tryptic digest was submitted to a preliminary 
fractionation on Sephadex G-50 tine (2.5 X 81 cm) 
in 50% acetic acid followed by ion-exchange chromato- 
graphy on SP-Sephadex C-25 (1 .O X 36 cm) and QAE- 
Sephadex A-25 (1 .O X 2 1 cm). The SP-Sephadex 
column was developed at 10.8 ml X hr-l X cmB2 
with a linear gradient of pyridine-acetic acid [ 161. 
The developing system for chromatography on QAE- 
Sephadex consisted of 3 linear gradients used in suc- 
cession. The first was made by mixing equal volumes 
[17] of 0.1 M triethylamine-O.1 MN-methyl- 
morpholine-0.05 M pyridine adjusted to pH 9.4 
with acetic acid and 0.1 M triethylamine-0.1 M N- 
methyhnorpholine-0.15 M pyridine adjusted to 
pH 6.6 with acetic acid. The second was made by 
mixing equal volumes of the latter buffer and 0.5 M 
acetic acid, and the third was generated from 0.5 M 
35 
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acetic acid and 2.0 M acetic acid as above. The 
QAE-Sephadex column was developed at 20 ml X hr-’ 
X cme2. All buffers contained 0.1% mercaptoethanol 
or thiodiglycol [ 181. Peptides were detected with nin- 
hydrin after alkaline hydrolysis [ 191 . 
3. Results 
The isolated fractions were subjected to automated 
Edman degradation using a technique similar to that 
described by Sauer et al. [20]. One particular fraction 
contained 3 different peptides. Eight degradation 
cycles allowed deduction of the following sequences: 
1. V?l-Phe-Glu-Arg-Cys-Glu-Leu-A&- 
14 
2. Arg-Leu-Gly-Met-Asp-Gly-Tyr-ikg- 
3. 9,8g)_Val-Val-Arg-Asp-Pro-Gln??$- 6 
Peptides 1 and 2 could be placed within the con- 
firmed sequence, l-79. One prolyl was identified as 
residue no. 71, but the sequence of peptide 3 did not 
agree with the sequence around this position. The se- 
cond proline residue in human milk and human 
leukemia lysozyme was reported to occupy position 
no. 102, but in this region only one valine residue was 
found [3,4]. 
-A?:-Val-Arg-Asp-Pro-Gln-A?;- 
As this sequence is identical with that of peptide 3, 
except for one valine residue, it is concluded that the 
additional valine demonstrated by amino acid analysis 
is present in a Val-Val sequence at positions 99-100. 
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